跳至主要内容
临床试验/EUCTR2019-004541-33-SE
EUCTR2019-004541-33-SE进行中(未招募)1 期

A clinical study to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer. - immvzmpr1

Västra Götalandsregionen0 个研究点目标入组 160 人开始时间: 2021年7月27日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children and young people (0-18.0 years) who start cancer treatment at the childhood cancer center in Gothenburg.
  • Known vaccination status for measles and chickenpox before start of cancer treatment.
  • Oral and written information for the study and signed consent form.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 160
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Known pre-existing primary immunodeficiency.
  • Patients planned for relapse therapy or will undergo allogeneic stem cell transplantation (SCT).
  • Known contraindication to any of the suggested vaccines.

研究者

相似试验